Du benytter en nettleser vi ikke støtter. Se informasjon om nettlesere

14. Referanser


Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716–59

Haugen BR Md, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward D, Tuttle RM Md, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid. 2015 Oct 14.

Leenhardt L,. Erdogan MF. Hegedus L,  Mandel SJ,  Paschke R,  Rago T, and G. Russa. 2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid Cancer. Eur Thyroid J. 2013 Sep; 2(3): 147–159.

Nasjonale retningslinjer for thyreoideacancer 2015: http://www.dahanca.oncology.dk

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Thyroid Carcinoma. Version 2.2015, NCCN.org

Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR; British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1–122.

Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787.

Smallridge, Ain, et al. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid 22(11): 1104-1139, 2012

UUICSverige (ikke nasjonale): www.oc.gu.se (2006) og www.ocsyd.lu.se (1999)

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567–610.


Ahmed SR, Ball DW. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 2011;96:1237–1245

Alex Stagnaro-Green et al. Guidelines of the Amarican Thyroid Association for Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid 2011; Volume 21, No 10, 1081–1125.

Asa SL.: My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004, 57, 225–32.

Baudin E, Travagli JP, Ropers J et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Carcinom1998; 83(3):553–559.

Berner A, Sigstad E, Pradhan M, Groholt KK, Davison B: Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals. Diagn Cytopathol 2006, 34, 97–100

Biermann, Martin; Kråkenes, Jostein; Brauckhoff, Katrin; Haugland, Hans Kristian; Akslen, Lars A.; Heinecke, A.; Varhaug, Jan Erik; Brauckhoff, Michael. 2015. Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity. Acta Radiol. 2015 Nov;56(11):1350–60

Biermann, Martin; Pixberg, M. K.; Riemann, B.; Schuck, A.; Heinecke, A.; Schmid, K. W.; Willich, N.; Dralle, H.; Schober, O. 2009. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer Results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin. 48: 89–98.

Bogsrud TV, Karantanis D, Nathan MA et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun. 2007; 28: 373–81.

Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Hay ID, Lowe VJ. The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Mol Imaging Biol. 2010 Oct;12(5):547–53.

Brose MS, Nutting CM, Jarzab B, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double blind, phase 3 trial. Lancet 2014; 384: 319–28

Brose MS, Smit J, Capdevila J, Elisei R, et al. Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma. Expert Rev Anticancer Ther 12:1137–47, 2012

Carter WB, Tourtelot JB, Savell JG, Lilienfeld H. New treatments and shifting paradigms in differentiated thyroid carcinommanagement. CarcinomControl. 2011 Apr;18(2):96–103.

Ceresini G, Corcione L, Morganti S, Milli B, Bertone L, Prampolini R, Petrazzoli S, Saccani M, Ceda GP, Valenti G. : Ultrasound-guided fine-needle capillary biopsy of thyroid nodules, coupled with on-site cytologic review, improves results. Thyroid. 2004, 14, 385–9.

Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM, Chapuis H, Lallemant JG, Lallemant B. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 2011;96:75–81

Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008;93:2173–2180

Choi KU, Kim JY, Park do Y, Lee CH, Sol MY, Han KT, Kim YG.: Recommendations for the management of cystic thyroid nodules. ANZ J Surg. 2005, 75, 537–41

Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Carcinom2003; 98(1):31–40.

Clinical Oncology 2004;16:561–68

Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167–214.

Cooper DS, Specker B, Ho M et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid CarcinomTreatment Cooperative Registry. Thyroid 1998; 8(9):737–744.

Daniels GH. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid 2011; 21:1199–1207

Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995 Jan;36(1):21–7.

Dralle H, Machens A, Brauckhoff M. Syndromic Medullary Thyroid Carcinoma: MEN 2A and MEN 2B. In: Randolph GW (Ed) Surgery of the thyroid and parathyroid glands. Elsevier Science. Philadelphia. 2nd edition. In press.

E.L. Mazzaferri. Approach to the pregnant patient with thyroid cancer. JCEM 96: 265–72, 2011

Elisei R, Schlumberger MJ, Müller SP, et al. Cabozantinib in Progressive Medullary Thyroid Cancer. J Clin Oncol 2013, 31:3639–46

Faggiano A, Milone F, Ramundo V, Chiofalo MG, Ventre I, Giannattasio R, Severino R, Lombardi G, Colao A, Pezzullo L. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. J Clin Endocrinol Metab 2010;95:E32-E36

Frates MC et al. Management of thyroid nodules detected at US: Society of Radiologists in ultrasound consensus conference statement. Radiology 2005; 237: 794–800.

Gharib H, Papini E, Paschke R et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive summary of recommendations. Endocrine Practice 2010; 16(3) May/June 468–475.

Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol. 1996, 15, 84–9.

Haslerud T1, Brauckhoff K2, Reisæter L3, Küfner-Lein R4, Heinecke A5, Varhaug JE6, Biermann M7. F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis. Acta Radiol. 2015 Jul 9. pii: 0284185115594645. [Epub ahead of print]

Hasselgren M, Hegedüs L, Godballe C, Bonnema SJ. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules. Head Neck 2010;32:612–618

Hassell LA, Gillies EM, Dunn ST.: Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing? CarcinomCytopathol. 2012 Feb 25;120(1):7–17.

Hay ID, Gonzalez-Losada T, Reinalda MS et al. Long-term outcome in 215 children and adolescents with papillary thyroid carcinomtreated during 1940 through 2008. World J Surg 2010; 34: 1192–202.

Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992; 112(6):1139–1146.

Hegedus L, Bonnema SJ, Bennedbaek FN. : Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003, 24, 102–32.

Heilo A, Sigstad E, Fagerlid KH, Håskjold OI, Grøholt KK, Berner A, Bjøro T, Jørgensen LH: Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism 06/2011; 96(9):2750–5.

Hoang JK, Langer JE, Middleton WD, Wu CC, Hammers LW, Cronan JJ, Tessler FN, Grant EG, Berland LL. Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee.J Am Coll Radiol. 2015 Feb;12(2)

Hung GU, Lee KW, Liao PY, Yang LH, Yang KT. The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer. Ann Nucl Med. 2008 Jul;22(6):481–5.

Ito Y, Tomoda C, Uruno T et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004; 28(11):1115–1121.

Ito Y, Tomoda C, Uruno T et al. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 2004; 28(5):498–501.

Ito Y, Uruno T, Nakano K et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13(4):381–387.

Jamshid Farahati et al.: Differentiated Thyroid Cancer. Carcinom1996; 77:172–80.

Jamshid Farahati et al.: Differentiated Thyroid Cancer. Carcinom1996; 77:172–80.

Karantanis D, Bogsrud TV, Wiseman GA et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007; 48: 896–901.

Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G; German Society for Endocrinology (DGE) – Thyroid Section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004;112: 52–58

Kim AW, Maxhimer JB, Quiros RM, Weber K, Prinz RA. Surgical management of well-differentiated thyroid carcinomlocally invasive to the respiratory tract. J Am Coll Surg 2005; 201(4):619–627.

Kim EK, Park CS, Chung WY et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol 2002; 178: 687–691.

Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, Jager PL,Links TP. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation. J Nucl Med. 2008 Apr;49(4):524–31.

Kouvaraki MA, Shapiro SE, Lee JE, Evans DB, Perrier ND. Surgical management of thyroid carcinoma. J Natl Compr Canc Netw 2005; 3(3):458–466.

Leboulleux S, Bastholt L, Krause T, et al. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double blind, phase 2 trial. Lancet Oncol 2012; 13: 897–905

Leenhardt L, Grosclaude P, Cherie-Challine L. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid CarcinomCommittee. Thyroid 2004; 14(12):1056–1060.

Lundh C, Lindencrona U, Postgård P, Carlsson T, Nilsson M, Forssell-Aronsson E. Ma C, Xie J, Lou Y, Gao Y, Zuo S, Wang X. The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis. Eur J Endocrinol. 2010 Aug;163(2):177–83.

M. Biermann et al.: Multicenter Study Differentiated Thyroid Carcinoma(MSDS). Diminished acceptance of adjuvant external beam radiotherapy. Nuclearmedizin 2003;42:244–50

Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 2010;95:2655–2663

Machens A, Hauptmann S, Dralle H. Medullary thyroid carcinomresponsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 2008;93:2234–2238

Machens A, Hoffmann F, Sekulla C, Dralle H. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer. 2009;16:1291–1298

Machens A, Lorenz K, Dralle H. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin nivås. Ann Surg 2009;250: 305–310

Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86(4):1447–1463.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. April 14, 2016.

Oertel YC, Oertel JE.: Thyroid cytology and histology. Baillieres Best Pract Res Clin Endocrinol Metab. 2000, 14, 541–57.

Orell SR, Philips J.: Broadsheet number 57: problems in fine needle biopsy of the thyroid. Pathology. 2000, 32, 191–8.

P.C.Wilson et al: Overview The Management of Advanced Thyroid Cancer. Clinical Oncology 2004;16:561–68

P.C.Wilson et al: Overview The Management of Advanced Thyroid Cancer.

Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 2006; 91:926–32.

Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787–803.

Papini E et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941–1946.

Papini E, Guglielmi R, Bianchini A et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87(5):1941–1946.

Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 2006;32:1144–8

Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004; 89(8):3713–3720.

Pillarisetty VG, Katz SC, Ghossein RA, Tuttle RM, Shaha AR. Micromedullary thyroid cancer: how micro is truly micro? Ann Surg Oncol 2009;16:2875–2881

Postgård P, Himmelman J, Lindencrona U, Bhogal N, Wiberg D, Berg G, Jansson S, Nyström E, Forssell-Aronsson E, Nilsson M. Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med. 2002 Jun;43(6):828–34.

Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW. 2006. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid carcinompatients. J Nucl Med; 47: 1260–6.

Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells. J Nucl Med. 2009 Jul;50(7):1161–7.

Raffel A, Cupisti K, Krausch M, Wolf A, Schulte KM, Roher HD. Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg 2004;28:397–401

Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006; 139(3):357–362.

Richard W. Tsang et al.: The Effect of Surgery, Radioiodine, and External Radiation Therapy on the Clinical Outcome of Patients with Differentiated Thyroid Carcinoma. Carcinom1998; 82:375–88.

Richard W. Tsang et al.:The Effect of Surgery, Radioiodine, and External Radiation Therapy on the Clinical Outcome of Patients with Differentiated Thyroid Carcinoma. Carcinom1998; 82:375–88.

Rosato L, Avenia N, Bernante P et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28(3):271–276.

Roti E, Rossi R, Trasforini G et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 2006; 91(6):2171–2178.

Saxena P, Bhatnagar A, Nishad DK, Tyagi R, Rana P, Ali S, Mittal G. Transient cell function disruption by low dose acute exposure of ionizing radiation. Indian J Exp Biol. 2011 Dec;49(12):895–903.

Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18(4):559–567.

Schlumberger M, De Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE, Pinchera A, Parmentier C. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid carcinompatients. J Nucl Med. 1996 Apr;37(4):606–12.

Schlumberger M, Pacini F, Wiersinga WM et al. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 2004; 151(5):539–548.

Sclumberger MJ, Tahara M, Wirth LJ, et al. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer. NEJM 2015; 372: 621–30

Shaha AR. Invited commentary: Vocal cord evaluation in thyroid surgery. Surgery 2006; 139(3):363–364.

Shimura H et al. Techniques in thyroidology. Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: A multicenter study. Thyroid 2005; 15:251–258.

Solbiati L et al. The thyroid gland. Textbook on diagnostic ultrasound chapter 21 by Rumenac CM, Wilson SR, Charboneau JW. Mosby 2002.

Tala H, Robbins R, Fagin JA, Larson SM, Tuttle RM. Five-year survival is similar in thyroid carcinompatients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. J Clin Endocrinol Metab. 2011 Jul;96(7):2105–11.

Tessler FN, Tublin ME. Thyriod sonography: Current application and future directions. Am J Roentgenol 1999; 173: 437–443.

The British Thyroid Association guidelines for the management of thyroid carcinomin adults. Fine needle aspiration cytology. https://www.british-thyroid-association.org/

Theoharis C, Roman S, Sosa JA: The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol. 2012 Jan;24(1):35–41. Review.

Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive CarcinomNetwork. Medullary carcinoma. J Natl Compr Canc Netw 2010;8:512–530

Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med. 2016 Aug 18;375(7):614-7

Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 2011;96:E109-E113

van Tol KM, Jager PL, Piers DA, Pruim J, de Vries EG, Dullaart RP, Links TP. Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid 2002; 12:381–7.

Wada N, Duh QY, Sugino K et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237(3):399–407.

Wang W, Larson SM, Fazzari M et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000; 85: 1107–13.

Wells SA Jr, Robinson BG, Gagal RF, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double blind phase III trial. J Clin Oncol 2012; 30:134–41

Yang GC, Liebeskind D, Messina AV.: Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer. 2003, 99, 69–74.

Siste faglige endring: 30. juni 2017